Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Guang-Wen Wei"'
Autor:
Serge Y. Fuchs, Xin-Yuan Liu, Da-Cheng Wang, Guang-Wen Wei, Rong-Bing Guo, Yuliya V. Katlinskaya, Kanstantsin V. Katlinski, Liang Chu, Hai-Neng Xu, Shuai Wu, Jing Xiao, Xian-Long Fang, Su-Jing Yuan, Xi-Jun Liu, Lie-Yang Chen, Yan-Ni Xu, Hui-Ling Li, Yuan-Qin Yang, Xiao-Fei Yin, Kang-Jian Zhang
Supplementary methods, tables, figures and legends to figures Supplementary Figure 1. The structure of AB loops for sIFN-I and IFNα-2b and comparison on the sequences for sIFN-I and IFNα-21. Supplementary Figure 2. Quantification of phosphorylaiton
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42d7d534bf96dd0984a42cde1954afaf
https://doi.org/10.1158/1078-0432.22466456.v1
https://doi.org/10.1158/1078-0432.22466456.v1
Autor:
Serge Y. Fuchs, Xin-Yuan Liu, Da-Cheng Wang, Guang-Wen Wei, Rong-Bing Guo, Yuliya V. Katlinskaya, Kanstantsin V. Katlinski, Liang Chu, Hai-Neng Xu, Shuai Wu, Jing Xiao, Xian-Long Fang, Su-Jing Yuan, Xi-Jun Liu, Lie-Yang Chen, Yan-Ni Xu, Hui-Ling Li, Yuan-Qin Yang, Xiao-Fei Yin, Kang-Jian Zhang
Purpose: Antiproliferative, antiviral, and immunomodulatory activities of endogenous type I IFNs (IFN1) prompt the design of recombinant IFN1 for therapeutic purposes. However, most of the designed IFNs exhibited suboptimal therapeutic efficacies aga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b3b4d772358fb107d6a9cddd1ecf806
https://doi.org/10.1158/1078-0432.c.6526319
https://doi.org/10.1158/1078-0432.c.6526319
Autor:
Rong-Bing Guo, Serge Y. Fuchs, Yuliya V. Katlinskaya, Haineng Xu, Kanstantsin V. Katlinski, Xinyuan Liu, Shuai Wu, Lieyang Chen, Fang Xianlong, Kangjian Zhang, Jing Xiao, Xiao-Fei Yin, Xi Jun Liu, Da-Cheng Wang, Hui-Ling Li, Liang Chu, Yuan-Qin Yang, Guang-Wen Wei, Yan-Ni Xu, Sujing Yuan
Purpose: Antiproliferative, antiviral, and immunomodulatory activities of endogenous type I IFNs (IFN1) prompt the design of recombinant IFN1 for therapeutic purposes. However, most of the designed IFNs exhibited suboptimal therapeutic efficacies aga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd92768b7d1f5508d47610f6222e352a
https://europepmc.org/articles/PMC5373932/
https://europepmc.org/articles/PMC5373932/
Publikováno v:
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition. 46(4)
To investigate the effect of recombinant super-compound interferon (rSIFN-co) on the proliferation and apoptosis of pulmonary adenocarcinoma cell line A549.Screening tests were conducted to determine the concentrations of rSIFN-co that have a signifi
Autor:
Ying Cai, Xin Cao, Chi-Hong Chao, Kai-Xian Chen, Kun Chen, Yi Chen, Liang Chu, Jian Ding, Miao Ding, Zhen-Yu Ding, Qi Dong, Jing Fan, Jun-Kai Fan, Erin M. Goldblatt, Jin-Fa Gu, Jennifer L. Hsu, He Huang, Jing-Yu Huang, Wenlin Huang, Wen-Lin Huang, Mien-Chie Hung, Hong-Bin Ji, Jing Jiang, Yu-Juan Jin, Ronald G. Jubin, Doranelly H. Koltchev, Eva Lee, Wen-Hwa Lee, Cui-Ping Li, Huang-Guang Li, Xiao Li, Anning Lin, Hong Liu, Hua Liu, Jing Liu, Jing-Yuan Liu, Leroy F. Liu, Lun-Xu Liu, Qiang Liu, Xin-Ran Liu, Xin-Yuan Liu, Yao-Hua Liu, Xin Lu, You-Yong Lu, Xiao-Min Luo, Yi Lisa Lyu, Lin Ma, Ze-Hong Miao, Wei Mo, Yun-wei Ou, Jian OuYang, Zhao-Hui Peng, Sidney Pestka, Qi-Jun Qian, Song-Bo Qiu, Rong-guang Shao, Jie Shen, Er-Wei Song, Yong-mei Song, Shi-Cheng Su, Yan Sun, Wei Tang, Diane Vy, Jian Wang, Jing-bo Wang, Li-Gang Wang, Lu-hua Wang, Guang-Wen Wei, Na Wei, Rui-Cheng Wei, Yu-Quan Wei, Shuai Wu, Zhi-Jiang Wu, Tian Xiao, Xiaoming Xie, Bin Xu, Bao-Feng Yang, Dong-Qin Yang, Kai-tai Yao, Feng-Yan Yu, Yi-Xin Zeng, Qi-min Zhan, Jian-Ting Zhang, Kang-Jian Zhang, Shu-Yuan Zhang, Su-Zhan Zhang, Yan-Hong Zhang, Zhen-Wei Zhang, Zi-Lai Zhang, Li-Li Zhao, Shi-Guang Zhao, Yong-su Zhen, Chao Zheng, Shu Zheng, Jin Zhou, Yong-Liang Zhu, Wei-Guo Zou, Ming Zuo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6e3c8f9686c9fff768f9531d9c2e963
https://doi.org/10.1016/b978-0-12-397833-2.00028-5
https://doi.org/10.1016/b978-0-12-397833-2.00028-5
Autor:
Xinyuan Liu, Jinfa Gu, Lin Ma, Liang Chu, Dong-Qin Yang, Xiao Li, Zhi-Jiang Wu, Cui-Ping Li, Kangjian Zhang, Jian Ding, Na Wei, Jian Wang, Jian OuYang, Ying Cai, Xinran Liu, Guang-Wen Wei, Miao Ding, Xin Cao, Huang-Guang Li, Lun-Xu Liu, Yi Chen, Ming Zuo
We have worked out two strong antitumor strategies, namely, two antitumor stars. One is the “Cancer Targeting Gene-Viro-Therapy, CTGVT” strategy and the other is the super interferon (sIFN-I) protein. By the combination of the above two antitumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::122e064f6fa6c27f5d3bf346919afee5
https://doi.org/10.1016/b978-0-12-397833-2.00021-2
https://doi.org/10.1016/b978-0-12-397833-2.00021-2
Publikováno v:
Cytokine. 63:254-255
We have discovered a new recombinant type I interferon and named it as Super Interferon-I (sIFN-I) which showed significant anti-virus and anti-tumor effect. Briefly, the EC50 for HIV, sIFN-I was about 1000 fold lower than that IFN α -2b. For Ebola